Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego|December 29, 2000
[Interactions between drugs and results of laboratory tests]P Milejski, K Orzechowska-JuzwenkoNeurologia I Neurochirurgia Polska|November 1, 1996
[Clinical significance of the pharmacogenetics in psychiatric and neurological syndromes]P Milejski, K Orzechowska-JuzwenkoNeurologia I Neurochirurgia Polska|November 1, 1987
[Occurrence of the fast acetylation phenotype in persons with the radicular syndrome. Preliminary report]P Milejski, K Orzechowska-Juzwenko, B Tota, et al.Toxicology Letters|August 1, 1984
Effect of chronic exposure to carbon disulfide on biotransformation of phenazone in rabbitsK Orzechowska-Juzwenko, T Wronska-Nofer, A Wiela, et al.International Journal of Clinical Pharmacology, Therapy, and Toxicology|October 1, 1990
Acetylator phenotype in patients with allergic diseases and its clinical significanceK Orzechowska-Juzwenko, P Milejski, J Patkowski, et al.Przeglad Lekarski|January 1, 1997
[Biotransformation of phenazone and sulfadimidine as markers of liver metabolism of drug and xenobiotic oxidation and acetylation in women with breast cancer]K Orzechowska-Juzwenko, A Wiela-Hojeńska, P Milejski, et al.Materia Medica Polona. Polish Journal of Medicine and Pharmacy|October 1, 1994
Genetically determined sparteine oxidation and sulfadimidine acetylation polymorphism in patients with non-occupational urinary bladder cancerK Orzechowska-Juzwenko, P Niewiński, J Pawlik, et al.Neurologia I Neurochirurgia Polska|February 15, 2000
[Clinical significance of oxidation and acetylation genetic polymorphism in patients with Parkinson's disease]P Milejski, K Orzechowska-Juzwenko, J Kamienowski, et al.Neurologia I Neurochirurgia Polska|July 1, 1996
[Clinical significance of the determination of oxidation and acetylation phenotype in patients with multiple sclerosis]P Milejski, K Orzechowska-Juzwenko, J Pawlik, et al.European Journal of Clinical Pharmacology|January 23, 2003
CYP2D6 extensive, intermediate, and poor phenotypes and genotypes in a Polish populationP Niewinski, K Orzechowska-Juzwenko, M Hurkacz, et al.Pageof 2